Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection

International Journal for Parasitology

Volumn 38, Issue 3-4, 2008, Pages 417-429

  Wanasen, Nanchaya ^a   Xin, Lijun ^a   Soong, Lynn ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Center for Biodefense and Emerging Infectious Diseases   (United States)

Author keywords

Antibodies; B cells; Cellular recruitment; Cutaneous leishmaniasis; Protozoan parasites; T cell activation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; MITOMYCIN C; PARASITE ANTIGEN;

ANTIBODY; CYTOLOGY; IMMUNE RESPONSE; LEISHMANIASIS; PATHOGEN; PROTOZOAN; RODENT;

ADOPTIVE TRANSFER; AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; FLOW CYTOMETRY; HISTOLOGY; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; MOUSE; MOUSE STRAIN; NONHUMAN; PATHOGENESIS; SPLEEN CELL; TISSUE NECROSIS;

ANIMALS; ANTIBODIES, PROTOZOAN; B-LYMPHOCYTES; BRAZIL; CD4-POSITIVE T-LYMPHOCYTES; COCULTURE TECHNIQUES; CYTOKINES; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HOST-PARASITE INTERACTIONS; IMMUNOHISTOCHEMISTRY; LEISHMANIA; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, DIFFUSE CUTANEOUS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS;

LEISHMANIA AMAZONENSIS; MURINAE; MUS; PROTOZOA;

EID: 38949195305     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2007.08.010     Document Type: Article

References (35)

1. Anderson C.F., Gerber J.S., and Mosser D.M. Modulating macrophage function with IgG immune complexes. J. Endotoxin Res. 8 (2002) 477-481
2. Barnes N., Gavin A.L., Tan P.S., Mottram P., Koentgen F., and Hogarth P.M. FcgammaRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16 (2002) 379-389
3. Brown D.R., and Reiner S.L. Polarized helper-T-cell responses against Leishmania major in the absence of B cells. Infect. Immun. 67 (1999) 266-270
4. Colmenares M., Constant S.L., Kima P.E., and McMahon-Pratt D. Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody. Infect. Immun. 70 (2002) 6597-6605
5. Constant S.L. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo. J. Immunol. 162 (1999) 5695-5703
6. Cupolilo S.M., Souza C.S., Abreu-Silva A.L., Calabrese K.S., and Goncalves da Costa S.C. Biological behavior of Leishmania (L.) amazonensis isolated from a human diffuse cutaneous leishmaniasis in inbred strains of mice. Histol. Histopathol. 18 (2003) 1059-1065
7. Duddy M.E., Alter A., and Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation?. J. Immunol. 172 (2004) 3422-3427
8. Dutta S., Ray D., Kolli B.K., and Chang K.P. Photodynamic sensitization of Leishmania amazonensis in both extracellular and intracellular stages with aluminum phthalocyanine chloride for photolysis in vitro. Antimicrob. Agents Chemother. 49 (2005) 4474-4484
9. Foote S.J., and Handman E. Genetics of murine leishmaniasis. Brief Funct. Genomic. Proteomic. 4 (2005) 270-276
10. Galvao-Castro B., Sa Ferreira J.A., Marzochi K.F., Marzochi M.C., Coutinho S.G., and Lambert P.H. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis. Clin. Exp. Immunol. 56 (1984) 58-66
11. Goldfeld A.E., Flemington E.K., Boussiotis V.A., Theodos C.M., Titus R.G., Strominger J.L., and Speck S.H. Transcription of the tumor necrosis factor alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells. Proc. Natl. Acad. Sci. USA 89 (1992) 12198-12201
12. Hailu A., Menon J.N., Berhe N., Gedamu L., Hassard T.H., Kager P.A., Olobo J., and Bretscher P.A. Distinct immunity in patients with visceral leishmaniasis from that in subclinically infected and drug-cured people: implications for the mechanism underlying drug cure. J. Infect. Dis. 184 (2001) 112-115
13. Hoerauf A., Solbach W., Rollinghoff M., and Gessner A. Effect of IL-7 treatment on Leishmania major-infected BALB.Xid mice: enhanced lymphopoiesis with sustained lack of B1 cells and clinical aggravation of disease. Int. Immunol. 7 (1995) 1879-1884
14. Howard J.G., Hale C., and Liew F.Y. Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica. J. Exp. Med. 152 (1980) 594-607
15. Ji J., Masterson J., Sun J., and Soong L. CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection. J. Immunol. 174 (2005) 7147-7153
16. Jones D.E., Buxbaum L.U., and Scott P. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 165 (2000) 364-372
17. Kane M.M., and Mosser D.M. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166 (2001) 1141-1147
18. Kima P.E., Constant S.L., Hannum L., Colmenares M., Lee K.S., Haberman A.M., Shlomchik M.J., and McMahon-Pratt D. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191 (2000) 1063-1068
19. Kleindienst P., and Brocker T. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunityin vivo. Immunology 115 (2005) 556-564
20. McMahon-Pratt D., and Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?. Immunol. Rev. 201 (2004) 206-224
21. Miles S.A., Conrad S.M., Alves R.G., Jeronimo S.M., and Mosser D.M. A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J. Exp. Med. 201 (2005) 747-754
22. Palanivel V., Posey C., Horauf A.M., Solbach W., Piessens W.F., and Harn D.A. B-cell outgrowth and ligand-specific production of IL-10 correlate with Th2 dominance in certain parasitic diseases. Exp. Parasitol. 84 (1996) 168-177
23. Qi H., Popov V., and Soong L. Leishmania amazonensis-dendritic cell interactions in vitro and the priming of parasite-specific CD4(+) T cellsin vivo. J. Immunol. 167 (2001) 4534-4542
24. Ravetch J.V., and Bolland S. IgG Fc receptors. Annu. Rev. Immunol. 19 (2001) 275-290
25. Rivera J., Zaragoza O., and Casadevall A. Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cells. Infect. Immun. 73 (2005) 1141-1150
26. Sacks D.L., Scott P.A., Asofsky R., and Sher F.A. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. J. Immunol. 132 (1984) 2072-2077
27. Scott P., Natovitz P., and Sher A. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis. J. Immunol. 137 (1986) 1017-1021
28. Soong L., Duboise S.M., Kima P., and McMahon-Pratt D. Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis. Infect. Immun. 63 (1995) 3559-3566
29. Soong L., Chang C.H., Sun J., Longley Jr. B.J., Ruddle N.H., Flavell R.A., and McMahon-Pratt D. Role of CD4+ T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158 (1997) 5374-5383
30. Tagami H. The role of complement-derived mediators in inflammatory skin diseases. Arch. Dermatol. Res. 284 Suppl. 1 (1992) S2-S9
31. Vanloubbeeck Y., and Jones D.E. Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection. Am. J. Trop. Med. Hyg. 71 (2004) 407-411
32. Waters W.R., Palmer M.V., Wannemuehler M.J., Sacco R.E., and Harp J.A. B cells are required for the induction of intestinal inflammatory lesions in TCRalpha-deficient mice persistently infected with Cryptosporidium parvum. J. Parasitol. 86 (2000) 1073-1077
33. Woelbing F., Kostka S.L., Moelle K., Belkaid Y., Sunderkoetter C., Verbeek S., Waisman A., Nigg A.P., Knop J., Udey M.C., and von Stebut E. Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J. Exp. Med. 203 (2006) 177-188
34. Yan J., Wolff M.J., Unternaehrer J., Mellman I., and Mamula M.J. Targeting antigen to CD19 on B cells efficiently activates T cells. Int. Immunol. 17 (2005) 869-877
35. Yang Z., Mosser D.M., and Zhang X. Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J. Immunol. 178 (2007) 1077-1085